USD 720,000 can be a Fine in China For Faking Vaccine Tests After Scandal

Recently highlighted Rabies vaccine scandal urged the Chinese government to amend their laws as it fulled public fears over domestically made medicines. A new law has been proposed and according to this law, a person can be charged/fined up to USD 720,000 who falsify test results or break other rules.  According to a draft posted on the website of China’s market regulator, the new law would also regulate processes including manufacturing, distribution, and use of vaccines.

Earlier this year, the country shocked by a scandal that saw a manufacturer of rabies vaccines fabricating records and while authorities keep on saying the affected vaccines did not enter the market. This case provoked outrage from consumers fed up with recurring product safety scandals, particularly in medicines.

With the new proposed law, those who break the rules can be fined up to 5.0 million yuan (USD 720,000) for offenses including submitting false test results, not recalling problematic batches and “other serious illegal acts”.

The drafted proposal words are ”those who involved in illegal behavior, shield or connive with violators, hide the facts through fabrication, or impede investigation will receive severe punishment.”

This is the very first time when any Chinese law has explicitly targeted vaccines, which were covered by regulations controlling medicine previously.

The Changchun Changsheng Biotechnology company was slapped by the Chinese authorities with a massive USD 1.3 billion in penalties over the rabies vaccine scandal.

14 people with the firm’s chairwoman were arrested in connection with the affair in July while more than a dozen national, provincial and local officials were sacked, including several senior officials from the drug regulatory agency.

China country hit by scandals involving sub-par or toxic food, drugs, and other products, despite repeated promises by the government to address the problem regularly. But with the rabies vaccine scandal, the Chinese authorities will become more strict and announced a nationwide inspection of laboratories producing vaccines.

Many of Chinese parents accepted that they have lost their trust and no longer have confidence in the pharmaceuticals administered to their children.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries